← Eichor
Condition: Esophageal Diseases Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Esophageal Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Changes in Sensitivity, Taste and Smell in Stroke Patients
Phase N/A · 1 location(s) · University of Giessen · NCT03240965Resilience and Equity in Aging, Cancer, and Health (REACH)
NA · 1 location(s) · Dana-Farber Cancer Institute · NCT04674267Dysphagia in Rheumatoid Arthritis
Phase N/A · 2 location(s) · Tanta University · NCT07401732a Single-arm, Single-center, Open Clinical Study
Phase N/A · 1 location(s) · Beijing Geekgene Technology Co., LTD · NCT06431100Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Phase N/A · 1 location(s) · University of Missouri-Columbia · NCT02838836Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
EARLY_Phase 1 · 1 location(s) · Vanderbilt-Ingram Cancer Center · NCT06828588Study of the Esophageal String Test (EST) for the Diagnosis of Helicobacter Pylori
NA · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06871579Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinom
Phase 2 · 1 location(s) · Anhui Provincial Hospital · NCT07188103A Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizuma
Phase 2/Phase 3 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT07554456The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
Phase N/A · 1 location(s) · Western Sydney Local Health District · NCT05804331DCE-MRI Based on 4D Free Breathing for Predicting Preoperative Neoadjuvant Chemoradiotherapy for Esophageal Cancer
NA · 1 location(s) · Yunnan Cancer Hospital · NCT06755866Tissue Collection Protocol for Gastroesophageal Cancers
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT02495337Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Phase 2 · 1 location(s) · Dallas VA Medical Center · NCT04018872Study of XB010 in Subjects With Solid Tumors
Phase 1 · 20 location(s) · Exelixis · NCT06545331Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic On
Phase 2 · 2 location(s) · Fudan University · NCT05281003An Innovative Endoscopic Cap for Dilating Benign Esophageal Strictures in Children
NA · 3 location(s) · University Children's Hospital, Zurich · NCT06675825Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia
NA · 1 location(s) · IRCCS San Camillo, Venezia, Italy · NCT05591040Striated Esophageal Motor Function Modulation in Health and Disease
NA · 1 location(s) · Medical College of Wisconsin · NCT05708885Innovative Patient-partner-guided Virtual Group Speech Pathology Intervention Model in Head and Neck Cancer
Phase 1/Phase 2 · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT05621889Effect of Thickened Feeds on Swallow Physiology in Children With Dysphagia
NA · 1 location(s) · Boston Children's Hospital · NCT04504227Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma
NA · 1 location(s) · Ruijin Hospital · NCT06596954Prospective Registry of EoSinophilic esOphagitis
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06443346Clinical Efficacy and Mechanism of tDCS for Dysphagia in PD
NA · 1 location(s) · Wang Ping · NCT07153692Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
Phase N/A · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT04892849Feeding Difficulties and Quality of Life in Children With Tracheal Cannula
Phase N/A · 2 location(s) · Karolinska Institutet · NCT06893458Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma（CR
Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT06509568Chemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol)
NA · 1 location(s) · University Health Network, Toronto · NCT06668454Esophageal Varices Prophylaxis in Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab
NA · 1 location(s) · Tanta University · NCT06961526Chemoradiotherapy for Advanced Esophageal Cancer
Phase 2 · 1 location(s) · AHS Cancer Control Alberta · NCT02297217A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Canc
Phase 1 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT06500052
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.